Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

被引:4
|
作者
Neilson, Aileen R. [1 ]
Jones, Gareth T. [2 ]
Macfarlane, Gary J. [2 ]
Pathan, Ejaz M., I [3 ]
McNamee, Paul [4 ]
机构
[1] Univ Edinburgh, Usher Inst, Edinburgh Clin Trials Unit ECTU, Edinburgh, Midlothian, Scotland
[2] Univ Aberdeen, Inst Appl Hlth Sci, Epidemiol Grp, Sch Med Med Sci & Nutr, Aberdeen, Scotland
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Dept Rheumatol, Newcastle Upon Tyne, Tyne & Wear, England
[4] Univ Aberdeen, Inst Appl Hlth Sci, Hlth Econ Res Unit, Sch Med Med Sci & Nutr, Aberdeen, Scotland
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2022年 / 23卷 / 08期
关键词
Mixture models; Utility mapping; Response mapping; EQ-5D-5L; BASDAI; BASFI; Axial spondyloarthritis; QUALITY-OF-LIFE; SEVERE ANKYLOSING-SPONDYLITIS; VARIABLE MIXTURE-MODELS; COST-EFFECTIVENESS; STATE UTILITY; OUTCOME MEASURES; VALUES; ETANERCEPT; FATIGUE; PAIN;
D O I
10.1007/s10198-022-01429-x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Preference-based health-state utility values (HSUVs), such as the EuroQol five-dimensional questionnaire (EQ-5D-5L), are needed to calculate quality-adjusted life-years (QALYs) for cost-effectiveness analyses. However, these are rarely used in clinical trials of interventions in axial spondyloarthritis (axSpA). In these cases, mapping can be used to predict HSUVs. Objective To develop mapping algorithms to estimate EQ-5D-5L HSUVs from the Bath Ankylosing Disease Activity Index (BASDAI) and the Bath Ankylosing Spondylitis Functional Index (BASFI). Methods Data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis (BSRBR-AS) provided 5122 observations with complete BASDAI, BASFI, and EQ-5D-5L responses covering the full range of disease severity. We compared direct mapping using adjusted limited dependent variable mixture models (ALDVMMs) and optional inclusion of the gap between full health and the next feasible value with indirect response mapping using ordered probit (OPROBIT) and generalised ordered probit (GOPROBIT) models. Explanatory variables included BASDAI, BASFI, and age. Metrics to assess model goodness-of-fit and performance/accuracy included Akaike and Bayesian information criteria (AIC/BIC), mean absolute error (MAE) and root mean square error (RMSE), plotting predictive vs. observed estimates across the range of BASDAI/BASFI and comparing simulated data with the original data set for the preferred/best model. Results Overall, the ALDVMM models that did not formally include the gap between full health and the next feasible value outperformed those that did. The four-component mixture models (with squared terms included) performed better than the three-component models. Response mapping using GOPROBIT (no squared terms included) or OPROBIT (with squared terms included) offered the next best performing models after the three-component ALDVMM (with squared terms). Simulated data of the preferred model (ALDVMM with four-components) did not significantly underestimate uncertainty across most of the range of EQ-5D-5L values, however the proportion of data at full health was underrepresented, likely due in part to model fitting on a small number of observations at this point in the actual data (4%). Conclusions The mapping algorithms developed in this study enabled the generation of EQ-5D-5L utilities from BASDAI/BASFI. The indirect mapping equations reported for the EQ-5D-5L facilitate the calculation of the EQ-5D-5L utility scores using other UK and country-specific value sets.
引用
收藏
页码:1357 / 1369
页数:13
相关论文
共 50 条
  • [1] Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data
    Aileen R. Neilson
    Gareth T. Jones
    Gary J. Macfarlane
    Ejaz MI Pathan
    Paul McNamee
    The European Journal of Health Economics, 2022, 23 : 1357 - 1369
  • [2] Eq-5d-5l utility scores for patients with breast cancer
    Torres, Sofia
    Bayoumi, Ahmed
    Trudeau, Maureen
    Abrahao, Ana Beatriz Kinupe
    Mitsakakis, Nicholas
    Krahn, Murray
    Liu, Geoffrey
    CANCER RESEARCH, 2022, 82 (04)
  • [3] Validity and reliability of EQ-5D-5L among patients with axial spondyloarthritis in Singapore
    Seng, Jun Jie Benjamin
    Kwan, Yu Heng
    Fong, Warren
    Phang, Jie Kie
    Lui, Nai Lee
    Thumboo, Julian
    Leung, Ying Ying
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 (02) : 71 - 78
  • [4] A mapping study in mainland China: predicting EQ-5D-5L utility scores from the psoriasis disability index
    Su, Juan
    Liu, Tong
    Li, Shunping
    Zhao, Yue
    Kuang, Yehong
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (07) : 737 - 743
  • [5] EQ-5D-5L and SF-6D health utility index scores in patients with myasthenia gravis
    Barnett, C.
    Bril, V.
    Bayoumi, A. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (03) : 452 - 459
  • [6] Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
    Edimansyah Abdin
    Siow Ann Chong
    Esmond Seow
    Swapna Verma
    Kelvin Bryan Tan
    Mythily Subramaniam
    Quality of Life Research, 2019, 28 : 177 - 186
  • [7] Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
    Abdin, Edimansyah
    Chong, Siow Ann
    Seow, Esmond
    Verma, Swapna
    Tan, Kelvin Bryan
    Subramaniam, Mythily
    QUALITY OF LIFE RESEARCH, 2019, 28 (01) : 177 - 186
  • [8] Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study
    Sahar Al Shabasy
    Fatima Al Sayah
    Maggie Abbassi
    Samar Farid
    The Patient - Patient-Centered Outcomes Research, 2022, 15 : 589 - 598
  • [9] Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study
    Al Shabasy, Sahar
    Al Sayah, Fatima
    Abbassi, Maggie
    Farid, Samar
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2022, 15 (05): : 589 - 598
  • [10] HEALTH UTILITY MEASURED WITH EQ-5D-5L IN JAPANESE PATIENTS UNDERGOING HEMODIALYSIS
    Saito, S.
    Noto, S.
    Miyazaki, M.
    VALUE IN HEALTH, 2016, 19 (07) : A860 - A860